Latest News for: pd l1

Edit

Head-to-Head Real-World Data: Cadonilimab Outperforms PD-1 Inhibitors in First-Line PD-L1-Low Gastric Cancer

The Daily Sentinel 14 Jan 2026
... against a PD-1 inhibitor plus chemotherapy… .
Edit

The 20 most exciting restaurants openings across the US

The Mercury News 13 Jan 2026
By Kat Odell, Bloomberg. Get ready to step up to the counter for some of the year’s more anticipated cooking ... It’s an efficient model that allows operators to trim labor costs while featuring fine-dining-calibre ingredients. RELATED ... Fatback, Chicago ... .
Edit

KAHR Bio Announces Strong Topline Phase 2 Results for DSP107 in Combination with Anti-PD-L1 Therapy in Colorectal Cancer

PR Newswire 08 Jan 2026
Phase 2 data demonstrated 17.5-month median overall survival in advanced, chemo-refractory patients with microsatellite stable colorectal cancer (MSS-CRC) ... DSP107 was evaluated in combination with atezolizumab (Tecentriq®), an anti–PD-L1 therapy ... Dr ... .
Edit

Author’s Tranquility Press Unveils High Stakes Sports Noir Thriller

GetNews 07 Jan 2026
A Championship Team Faces Collapse in Carlo Armenise's New Mystery, Sam Razor Private Investigator The Backcourt Blackmailer. MARIETTA, GA - A ticking clock. A seventy-five-million-dollar threat. A superstar's legacy on the line ... About the Author ... Email.
Edit

Game Balls (Dec. 15-Jan. 3): Local wrestlers shine at Christmas tournament

The Tribune Greeley 06 Jan 2026
The opening weeks of the high school sports winter season create interesting momentum. Local basketball players, wrestlers, swimmers, divers and hockey players begin to gravitate toward midseason form only to have a couple weeks off for winter break.
Edit

Kelun-Biotech Announces Breakthrough Therapy Designation Granted in China for Sacituzumab Tirumotecan (sac-TMT) in Combination with Immunotherapy Pembrolizumab for First-Line Treatment of PD-L1-Positive NSCLC

PR Newswire 05 Jan 2026
... In combination with anti-PD-L1 monoclonal antibody tagitanlimab for the first-line treatment of locally advanced or metastatic non-squamous NSCLC without actionable genomic alterations in June 2025.
Edit

Winning numbers drawn in Thursday’s Michigan Keno

Traverse City Record-Eagle 26 Dec 2025
The winning numbers in Thursday's drawing of the "Michigan Keno" game were. 4, 5, 9, 15, 16, 20, 25, 26, 28, 30, 33, 35, 36, 38, 44, 48, 49, 52, 57, 65, 72, 75 ... .
Edit

NFL Week 17 picks: Why the Eagles and Titans are live road underdogs this weekend

CBS Sports 25 Dec 2025
We got an early Christmas gift last week, as I enjoyed one of my most successful betting weeks of the season. For the Week 16 slate, I correctly picked 12 of the 16 games on the moneyline and was 10-5-1 ATS overall ... Locks of the Week ATS. 42-38-0. ATS ... .
Edit

Why mosquitoes bite you more: The surprising science behind being a 'mosquito magnet'

The Times of India 24 Dec 2025
If you have ever stood outside with friends and watched mosquitoes ignore everyone else while repeatedly landing on you, the experience can feel personal. Scientists say it is not ... Mosquitoes then use sight to narrow in on a target ... .
Edit

MLKL/retromer axis controls PD-L1 recycling to compromise antitumor immunity during VCP inhibition–induced necroptosis

PNAS 16 Dec 2025
SignificanceTumor cells exploit programmed death ligand 1 (PD-L1) for ...
Edit

14-year-old Milwaukee boy charged with killing 15-year-old in robbery over gun

Milwaukee Journal Sentinel 11 Dec 2025
MPD Chief Jeffrey Norman says social media fuels youth gun deaths. Milwaukee Police Chief Jeffrey Norman discusses the prevalence of guns among youth and the need for social media guardrails ... Amud J. Newburn was charged Dec ... The shooting took place Nov.
Edit

CytoDyn to Showcase PD-L1 Upregulation and Improved Survival in Metastatic Triple Negative

Enid News & Eagle 08 Dec 2025
Leronlimab treatment is associated with upregulation of PD-L1 in circulating tumor cells and cancer-associated macrophage-like cells ... .
Edit

CytoDyn to Showcase PD-L1 Upregulation and Improved Survival�in Metastatic Triple Negative Breast Cancer�at the San ...

Nasdaq Globe Newswire 08 Dec 2025
Leronlimab treatment is associated with upregulation of PD-L1 in circulating tumor cells and cancer-associated macrophage-like cells ... .
Edit

PD-L1 X 4-1BB (CD137) Bispecific Antibodies Pipeline and Competitive Intelligence Report 2025

Nasdaq Globe Newswire 27 Nov 2025
The main market opportunities for PD-L1 x 4-1BB bispecific antibodies lie in their ability to enhance antitumor responses while ...
Edit

Kelun-Biotech Announces Phase III Trial of Sac-TMT in Combination with KEYTRUDA® (pembrolizumab) as First-Line Treatment for PD-L1-Positive NSCLC Met Primary Endpoint

PR Newswire 24 Nov 2025
... of sac-TMT in combination with pembrolizumab versus pembrolizumab monotherapy as first-line treatment of patients with PD-L1-positive locally advanced or metastatic NSCLC with PD-L1 TPS ≥ 1%.

Article Search

tools
×
×
×
×